SPS
MDGL icon

Susquehanna Portfolio Strategies’s Madrigal Pharmaceuticals MDGL Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8M Buy
22,003
+15,753
+252% +$8.07M 0.19% 144
2026
Q1 		$3.27M Hold
6,250
– – 0.05% 389
2025
Q4 		$3.64M Hold
6,250
– – 0.06% 367
2025
Q3 		$2.87M Hold
6,250
– – 0.05% 433
2025
Q2 		$1.89M Buy
+6,250
New +$1.86M 0.04% 385

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Susquehanna Portfolio Strategies's MDGL Position: Q2 2026 in Review

Susquehanna Portfolio Strategies increased its Madrigal Pharmaceuticals (MDGL) stake by 252% in Q2 2026, buying an estimated $8.07M and bringing the position to 22,003 shares worth $11.8M. The position accounts for 0.19% of the portfolio, ranked #144.

Susquehanna Portfolio Strategies first reported a position in MDGL in Q2 2025 and has held it in 5 quarters since. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Susquehanna Portfolio Strategies held 22,003 shares of Madrigal Pharmaceuticals worth $11.8M as of Q2 2026.
  • Susquehanna Portfolio Strategies bought 15,753 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $8.07M.
  • Madrigal Pharmaceuticals made up 0.19% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #144 holding.
  • Susquehanna Portfolio Strategies first reported a position in Madrigal Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.